MedPAC > Our Work > Delivery System Reforms > MedPAC comment on OIG’s proposed rule on safe harbor regulation of prescription drug rebates MedPAC comment on OIG’s proposed rule on safe harbor regulation of prescription drug rebates Apr 05, 2019 / Comment Letters Download Full Comment Letter